Insider Buying: Cytomedix Insider Buys 48,000 Shares of Stock (CMXI)
Cytomedix (NASDAQ:CMXI) Insider Dean Tozer purchased 48,000 shares of the stock on the open market in a transaction dated Wednesday, August 20th. The shares were purchased at an average cost of $0.39 per share, with a total value of $18,720.00. Following the completion of the transaction, the insider now directly owns 48,000 shares of the company’s stock, valued at approximately $18,720. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
Cytomedix (NASDAQ:CMXI) remained flat at $0.40 during trading on Thursday. The stock had a trading volume of 60,694 shares. Cytomedix has a 52-week low of $0.33 and a 52-week high of $0.68. The stock’s 50-day moving average is $0.39 and its 200-day moving average is $0.47. The company’s market cap is $49.8 million.
Cytomedix, Inc is a United States-based company that develops biologically active regenerative therapies for wound and tissue repair.
Receive News & Ratings for Cytomedix Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cytomedix Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.